Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The thread of life -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (70)	12/5/2000 6:59:22 PM
From: Mike McFarland	Respond to of 1336

<AXPH where management is surely weak> Paul J. Hastings appointed President and CEO effective January 1. axyspharm.com Please--no more of this creative financing. Issue no more shares. Stop the madness! quote.yahoo.com

To: Mike McFarland who wrote (70)	12/5/2000 8:08:07 PM
From: Extra Pale	Read Replies (2) \| Respond to of 1336

Mike, When is Aria going to partner something!!!! My sense from hearing Berger a couple of times is that he is very arrogant about aria's technology -- I think he wants to go it a lone, or until he can write his own ticket. Good chance he strikes out; but maybe they do have something unique and valuable within a couple of years... Owned DNDN but sold for a nice profit while weaning some of the vaccine plays out of the port. Consider both gzmo & cege to be better bargains at current market caps. Know absolutely nothing about axph, will look into it. Regards lgnd, is any bio as frustrating? Lets face it, guidance by discovery stage bio management teams is basically worthless. Between the science unknowns and mgmt ignorance, its all a crap shoot... Am concerned about today's rally setting us up for a big fall. Biggest one day up in history cause the fed acknowledges the economy is slowing big time? was nothing but a poor excuse to party. Cheers!